首页> 美国卫生研究院文献>Journal of Clinical and Translational Research >Connexin-based signaling and drug-induced hepatotoxicity
【2h】

Connexin-based signaling and drug-induced hepatotoxicity

机译:基于连接蛋白的信号传导和药物诱导的肝毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Being critical mediators of liver homeostasis, connexins and their channels are frequently involved in liver toxicity. In the current paper, specific attention is paid to actions of hepatotoxic drugs on these communicative structures. In a first part, an overview is provided on the structural, regulatory and functional properties of connexin-based channels in the liver. In the second part, documented effects of acetaminophen, hypolipidemic drugs, phenobarbital and methapyriline on connexin signaling are discussed. Furthermore, the relevance of this subject for the fields of clinical and in vitro toxicology is demonstrated.>Relevance for patients: The role of connexin signaling in drug-induced hepatotoxicity may be of high clinical relevance, as it offers perspectives for the therapeutic treatment of such insults by interfering with connexin channel opening.
机译:连接蛋白及其通道是肝脏动态平衡的关键介质,经常参与肝毒性。在当前的论文中,应特别注意肝毒性药物在这些交流结构上的作用。在第一部分中,概述了肝脏中基于连接蛋白的通道的结构,调控和功能特性。在第二部分中,讨论了对乙酰氨基酚,降血脂药,苯巴比妥和甲萘必林对连接蛋白信号传导的影响。此外,还证明了该主题与临床和体外毒理学领域的相关性。>对患者的相关性:连接蛋白信号传导在药物诱导的肝毒性中的作用可能具有高度的临床相关性,因为它提供了通过干扰连接蛋白通道开放来治疗此类损伤的观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号